ISU Abxis

At a glance

ISU Abxis filed 36 disclosures in the last 12 months, including 3 earnings, 3 insider and 1 5% holder. The most recent key filing was on Aug 6: Operating profit ₩479M, down 94.9% YoY. Revenue ₩14.9B, down 34.6% YoY.

Revenue for 2025 was ₩56.7B, down 6% on 2024. Operating margin was 2.9% against 22.2% a year earlier. Debt was 39% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩24.4B and operating loss of ₩3B.

The 2025 annual report lists 190 employees with an average tenure of 4.9 years and average pay of ₩59.9M, #1153 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩232M each on average. It paid no cash dividend for 2025. (주)이수화학 and related parties held 36.12% at year end.

Of 1 recent 5%+ holder report, 0 raised and 1 cut a stake; the largest stake reported was 35.93% on Jul 23.

From the 2025 annual report

Staff: 190 (95 men, 95 women), of whom 7 on fixed-term contracts. Total pay for the year: ₩11.4B. Directors and auditors: 5, paid ₩1.2B in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)이수화학 holds 32.19%; with 5 related parties the group holds 36.12% of common shares at year end (from 35.07% at the start of the year).

Individuals paid ₩500M or more

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports